Monday, 19th May AUS-oMicS 2025

Unleashing flexibility: ZenoTOF 7600+ for unmatched speed and unique PTM analysis

Presenters: Jeremy Potriquet, Omics Application Specialist, SCIEX and a special guest speaker.

• So Why Is Biomarker Validation Difficult in Metabolomics? What's Working and Not (Yet) Working - Daniel Raftery

• Targeting microsatellite stable colorectal cancer (MSS-CRC) with novel forms of immunotherapy. - Wei Wu
• The Multiverse: Immune Recognition of Cancer Through Diverse Biomolecules - Anthony W Purcell
• Surface proteomic analysis reveals the present of non-canonical cell membrane ER chaperone proteins in high-grade gliomas - Angelica Merlot
• Clinical validation of a diagnostic test for esophageal adenocarcinoma based on a novel serum glycoprotein biomarker panel: PromarkerEso - Scott Bringans
• ST6GAL1-mediated sialyl linkage switching in tumor-associated macrophages drives cancer-promoting nanotubes carrying α2,6-sialylation in anti-inflammatory cells - Priya Dipta

• From Bench to Impact: Advancing Ovarian Cancer Detection with Glycoproteomics and LeMBA-MS - Michelle Hill

Presenters:
1. Christophe Crisp, Bruker - 4D Proteomics: From Biosample to BioInsights
2. TBC
3. Michele Zani, BBIO - Standardized NMR Metabolomics for Human Health: Innovations and Applications

• Applications of Molecular Phenomics in Healthcare. - Elaine Holmes

• Generating new environmental and biological insights into PFAS pollution with mass spectrometry - Oliver A H Jones

• Plasma immunopeptidomics – a liquid biopsy of tumour antigen presentation - Kirti Pandey
• QUANTITATIVE INTERACTOME MAPPING OF SKELETAL MUSCLE INSULIN RESISTANCE TO PROBE DYNAMIC CHANGES IN PROTEIN:PROTEIN INTERACTIONS - Yaan Kit YN Ng

• Integrating Olink proteomics and human organoids to model sepsis-induced organ failure - Harley R Robinson
• Immunoenrichment for peptide lysine acetylation and histopathology reveal hepatic adaptations to type 2 diabetes - Jackie Zhou
• Global analysis of endogenous protein disorder in cells - Shouxiang Zhang

• Multi-Glycomics on the path to Multi-Omics - Nicolle Packer

• Leveraging Native Mass Spectrometry for Hit Identification in Drug Discovery: A Powerful Tool for Detecting Protein-Ligand Interactions - Amanda Bergamin

15:35 - 15:45 - Award Presentation

15:45 - 16:15 - Larisa Dirr

• Glycan-binding and glycan-processing proteins as anti-infective drug targets - Larissa Dirr

• Impact of Different Pathogen Classes on the Serum N-Glycome in Septic Shock - The Huong Chau

• Arteriovenous sampling for organ-specific metabolic insights in CKM syndrome - Dana Hicks
• Comprehensive discovery lipidomic workflow which utilizes a multi-reflecting ToF with integrated informatics, providing highly confident lipid characterization and quantification - Caryn Hepburn
• Differential associations of truncal and appendicular fat and lean mass indices with plasma lipids and lipoproteins - Alanah A Grant-St James

• Plasma proteomics – learnings from the Munich area and Germany-wide ring trials - Stefanie Hauck